Literature DB >> 31456177

Epidemiology of Breast Cancer in Women.

Steven S Coughlin1.   

Abstract

Epidemiologic studies have contributed importantly to current knowledge of environmental and genetic risk factors for breast cancer. Worldwide, breast cancer is an important cause of human suffering and premature mortality among women. In the United States, breast cancer accounts for more cancer deaths in women than any site other than lung cancer. A variety of risk factors for breast cancer have been well-established by epidemiologic studies including race, ethnicity, family history of cancer, and genetic traits, as well as modifiable exposures such as increased alcohol consumption, physical inactivity, exogenous hormones, and certain female reproductive factors. Younger age at menarche, parity, and older age at first full-term pregnancy may influence breast cancer risk through long-term effects on sex hormone levels or by other biological mechanisms. Recent studies have suggested that triple negative breast cancers may have a distinct etiology. Genetic variants and mutations in genes that code for proteins having a role in DNA repair pathways and the homologous recombination of DNA double stranded breaks (APEX1, BRCA1, BRCA2, XRCC2, XRCC3, ATM, CHEK2, PALB2, RAD51, XPD), have been implicated in some cases of breast cancer.

Entities:  

Keywords:  Alcohol; Breast cancer; Diet; Epidemiology; Genetics; Physical activity

Mesh:

Substances:

Year:  2019        PMID: 31456177     DOI: 10.1007/978-3-030-20301-6_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  61 in total

1.  Impact of genetic variants in IL-2RA and IL-2RB on breast cancer risk in Chinese Han women.

Authors:  Lingge He; Wenjie Zhang; Shuangyu Yang; Wenting Meng; Xia Dou; Jianfeng Liu; Yuanwei Liu; Haiyue Li; Tianbo Jin
Journal:  Biochem Genet       Date:  2021-01-28       Impact factor: 1.890

2.  Early Diagnostic Markers and Therapeutic Targets for Experimental Breast Cancer.

Authors:  N N Ermakova; O V Pershina; M A Zhukova; A V Pakhomova; E S Pan; L A Sandrikina; V A Krupin; O Yu Rybalkina; A M Dygai; E G Skurikhin
Journal:  Bull Exp Biol Med       Date:  2022-05-02       Impact factor: 0.804

3.  Prognostic Significance of p16 Protein Expression in Breast Cancer.

Authors:  Magdi M Salih; Amjed A Higgo; Emad M Eed
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

4.  Effect of intravenous lidocaine infusion on perioperative cellular immunity and the quality of postoperative recovery in breast cancer patients: a randomized controlled trial.

Authors:  Qingfeng Wei; Ming Xia; Qin Zhang; Zhiping Wang
Journal:  Gland Surg       Date:  2022-03

Review 5.  Comprehensive comparison of theranostic nanoparticles in breast cancer.

Authors:  Amin Nikdouz; Nima Namarvari; Ramin Ghasemi Shayan; Arezoo Hosseini
Journal:  Am J Clin Exp Immunol       Date:  2022-02-15

6.  Prepectoral breast reconstruction: an ideal approach to bilateral risk-reducing mastectomy.

Authors:  Michele Maruccia; Rossella Elia; Pasquale Tedeschi; Angela Gurrado; Marco Moschetta; Mario Testini; Giuseppe Giudice
Journal:  Gland Surg       Date:  2021-10

7.  The Mammary Tumor Microenvironment.

Authors:  Colleen S Curran; Suzanne M Ponik
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  dNLR and TILS can be used as indicators for prognosis and efficacy evaluation of neo-adjuvant chemotherapy in breast cancer.

Authors:  Xiaorui Wang; Weipeng Zhao; Lihong He; Shuling Wang; Weidong Li; Jing Wang; Zhongsheng Tong
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 9.  Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer.

Authors:  Sonia Missiroli; Mariasole Perrone; Caterina Boncompagni; Chiara Borghi; Alberto Campagnaro; Francesco Marchetti; Gabriele Anania; Pantaleo Greco; Francesco Fiorica; Paolo Pinton; Carlotta Giorgi
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

10.  Targeting a cell surface vitamin D receptor on tumor-associated macrophages in triple-negative breast cancer.

Authors:  Wadih Arap; Renata Pasqualini; Fernanda I Staquicini; Amin Hajitou; Wouter Hp Driessen; Bettina Proneth; Marina Cardó-Vila; Daniela I Staquicini; Christopher Markosian; Maria Hoh; Mauro Cortez; Anupama Hooda-Nehra; Mohammed Jaloudi; Israel T Silva; Jaqueline Buttura; Diana N Nunes; Emmanuel Dias-Neto; Bedrich Eckhardt; Javier Ruiz-Ramírez; Prashant Dogra; Zhihui Wang; Vittorio Cristini; Martin Trepel; Robin Anderson; Richard L Sidman; Juri G Gelovani; Massimo Cristofanilli; Gabriel N Hortobagyi; Zaver M Bhujwalla; Stephen K Burley
Journal:  Elife       Date:  2021-06-01       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.